XML 25 R14.htm IDEA: XBRL DOCUMENT v3.20.2
Note 8 - Employee Benefits
9 Months Ended
Sep. 30, 2020
Notes to Financial Statements  
Share-based Payment Arrangement [Text Block]
8.
EMPLOYEE BENEFITS

 
ESOP
 

 
In connection with our conversion and public offering, we established an ESOP. The ESOP borrowed from the Company to purchase
350,000
shares in the offering. The issuance of the shares to the ESOP resulted in a contra account established in the equity section of the balance sheet for the unallocated shares at an amount equal to their
$10.00
per share purchase price.
 
The Company
may
make discretionary contributions to the ESOP and pay dividends on unallocated shares to the ESOP. ICC makes annual contributions to the ESOP sufficient to repay the loan. When loan payments are made, ESOP shares are allocated to participants based on relative compensation.  
No
contributions to the ESOP were made during the
nine
months ended
September 30, 2020
and
2019
, respectively.
 
A compensation expense charge is booked monthly during each year for the shares committed to be allocated to participants that year, determined with reference to the fair market value of our stock at the time the commitment to allocate the shares is accrued and recognized. For the
nine
months ended
September 30, 2020
, we
recognized compensation expense
of $
206,535
related to 
17,546
shares of our common stock that are committed to be released to participants' accounts at
December 31, 2020.
Of the
17,546
 shares committed to be released, 
1,921
shares were committed on
September 30, 2020
and had
no
impact on the weighted average common shares outstanding for the 
three
and
nine
months ended
September 30, 2020
. For the
nine
months ended
September 30, 2019
, we recognized compensation expense of $
233,135
related to 
17,530
shares of our common stock that were committed to be released to participants' accounts at
December 31, 2019
. Of the
17,530
 shares committed to be released at
December 31, 2019
1,926
shares were committed on
September 30, 2019
and had
no
impact on the weighted average common shares outstanding for the
three
and
nine
months ended
September 30, 2019
.  
 
RESTRICTED STOCK UNITS
 

 
Restricted stock units (RSUs) were granted for the
first
time in
February 2018
with additional RSUs granted in
March 2019
and
April 2020.
RSUs have a grant date value equal to the closing price of the Company's stock on the dates the shares are granted. The RSUs vest
1/3
over
three
years from the date of grant.
 
As of
September 30, 2020
,
18,040,
 
13,071,
and
11,700
RSUs have been granted
at a fair market value of
$11.03,
 
$13.70,
and
$15.10,
respectively. We recognized $
126,588
and $
78,226
of expense on these units in the
nine
months ended
September 30, 2020
and
September 30, 2019
, respectively. Total unrecognized compensation expense relating to outstanding and unvested RSUs was $
269,359
 as of
September 30, 2020
, which will be recognized over the remainder of the
three
-year vesting periods.